ConductScience.org, home

Paper21571

An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.

Mielke DH and 2 others. Am J Psychiatry, 1977. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels. Papers, record 21571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21571

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
PubMed
Journal
Am J Psychiatry
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mielke DHD H
2Gallant DMD M
3Kessler CC

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Growth HormoneMajor topic
ProlactinMajor topic
SchizophreniaMajor topic
SulpirideMajor topic
Adult
Antipsychotic Agents
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Evaluation
Dyskinesia, Drug-Induced
Female
Humans
Hypothalamus
Male

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
32879783Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy.Transl Vis Sci Technol2020https://conductscience.org/library/papers/32879783PubMed
18598092Practical issues with amisulpride in the management of patients with schizophrenia.Clin Drug Investig2008https://conductscience.org/library/papers/18598092PubMed
10796605Sulpiride for schizophrenia.Cochrane Database Syst Rev2000https://conductscience.org/library/papers/10796605PubMed
8800626A risk-benefit assessment of sulpiride in the treatment of schizophrenia.Drug Saf1996https://conductscience.org/library/papers/8800626PubMed
6785794A clinical and pharmacodynamic evaluation of sulpiride.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6785794PubMed
6532808Autoradiographic study of 14C-sulpiride in monkey.Eur J Drug Metab Pharmacokinet1984https://conductscience.org/library/papers/6532808PubMed
6427815Effects of chronic sultopride treatment on endocrine systems in psychotic women.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6427815PubMed
6417717A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6417717PubMed
6412271Sulpiride trial in chronic schizophrenia with comparison of two dosage regimens.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6412271PubMed
6162168Brain locations controlling the behavioral effects of chronic amphetamine intoxication.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6162168PubMed
2568655Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2568655PubMed
1969667Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.Psychopharmacology (Berl)1990https://conductscience.org/library/papers/1969667PubMed
477842The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.Experientia1979https://conductscience.org/library/papers/477842PubMed
115033Effect of sulpiride on monoaminergic mechanisms in psychotic women.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/115033PubMed
44375Sulpiride in tardive dyskinesia.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/44375PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21571

GET https://conductscience.org/api/papers/v1/21571/authors